Chinese herbal medicine: From Shennong to modern times

The history of Chinese herbal medicine begins with a legendary ruler, physician and herbalist named Shennong, the Divine Farmer. Tradition credits him with tasting plants and recording their effects, an image expressing the close observation of nature at the heart of early healing. The text associated with him, the Shennong Bencao Jing, describes 365 substances in upper, middle and lower grades. It was assembled over centuries rather than written at once, so Shennong functions as a figure in collective memory and a cultural symbol.

Chinese herbal medicine is a broad family of practices rather than a fixed collection of remedies. Its central records are materia medica, while its most practical works are formula texts, in which substances are combined to address patterns of signs and symptoms. Decoctions, powders, pills and medicinal foods sit alongside acupuncture, moxibustion, dietetics and exercise traditions. Treatment has also been shaped by trade, epidemics, household recipes, court physicians and local plant knowledge.

Over time, this evolving knowledge met chemical analysis, colonial medicine, pharmaceutical manufacture, political campaigns and modern regulation. In Australia, Chinese herbal medicines now sit within a consumer market governed by the Therapeutic Goods Administration, while practitioners work within a national registration scheme. Comparing the major periods shows that continuity and change have always been central to the story.

Period	Representative record	Defining development
Legendary foundations	Shennong Bencao Jing	365 graded substances linked to properties, uses and risk
Han dynasty	Zhang Zhongjing's Shanghan Zabing Lun	Symptom patterns connected with timing, dosage and formulas
Tang dynasty	Xin Xiu Ben Cao (659)	About 850 substances and extensive illustration under court sponsorship
Song dynasty	Tujing Ben Cao and Bencao Mengdui	Printed and illustrated catalogues expanded state oversight
Ming dynasty	Li Shizhen's Bencao Gangmu (1578)	Critical synthesis of sources, observation, formulas and corrections
Qing to modern	Later supplements, pharmacopoeias and WHO classification	Scientific testing, manufacturing standards and international regulation

Roots before the written canon

Before written materia medica, medicine was embedded in oral instruction, household practice and specialist knowledge of local plants, animals and minerals. Shamans, herb collectors, healers and families all contributed, and remedies travelled through migration, warfare and trade. Later physicians idealised this knowledge, so the remote past cannot be reconstructed from later texts alone. Archaeology and ethnobotany reveal a broader origin than the Shennong story suggests.

The Shennong Bencao Jing marks a shift toward organised recording. Entries describe a substance's flavour, warming or cooling action, toxicity and principal effects. Three grades placed beneficial substances in the upper class, nourishing or corrective ones in the middle class, and stronger or more toxic ones in the lower class. This was an early taxonomy of use and risk, not a modern clinical trial system.

Ingredients included barks, roots, seeds, leaves, flowers, insects, bones and minerals. Familiar examples include ginger, cinnamon, ephedra, ginseng and licorice. Agricultural expansion increased access to cultivated plants, while routes linking northern and southern China introduced new ingredients into formularies. Manuscripts and later printing helped specialists compare names, appearances and preparation methods across regions.

Han dynasty medicine and pattern-based prescribing

The Han dynasty (206 BCE–220 CE) brought the clearest surviving expansion of medical thought. In the early third century, Zhang Zhongjing wrote the Shanghan Zabing Lun, commonly translated as the Treatise on Cold Damage and Miscellaneous Diseases. Its case discussions paired symptom patterns with timing, dosage and formulas. Later physicians valued the work so highly that many commentaries were organised around it.

Other texts widened the practical field. The Jingui Yaolue, also associated with Zhang, addressed women's disorders, labour, fluids and miscellaneous conditions. New materia medica added substances and corrected descriptions. Mineral and animal medicines could be potent or hazardous. Writings on pulse diagnosis, bodily fluids and channels placed herbs within a developing account of the body, though these concepts emerged gradually rather than appearing fully formed in one text.

By the late Han, yin and yang, the five phases and pattern differentiation were becoming influential. Physicians did not simply match a disease name to an herb; they assessed combinations such as cold, heat, deficiency and excess. This framework made prescribing adaptable, but it demanded training and judgement. Materia medica therefore joined empirical observation to a cosmology inseparable from its cultural setting.

Tang and Song expansion through trade and printing

Tang China was a cosmopolitan medical environment. Silk Road commerce carried aromatics, resins, minerals and medicines among China, Central Asia and the Middle East. Court sponsorship produced major catalogues, including the Xin Xiu Ben Cao of 659, which recorded about 850 substances with hundreds of illustrations. Images helped identify plants and improve quality control, although written descriptions remained necessary where colour and form varied.

Song printing accelerated the reach of medical knowledge. Officials and scholars produced illustrated pharmacopoeias, while printed formularies made specialised combinations more accessible. The Tujing Ben Cao of 1061 described more than 1,500 substances with roughly a thousand illustrations, and the later Bencao Mengdui became an important court reference. These projects reflected growing oversight without erasing local healers' contributions.

Commercial medicine flourished through itinerant doctors, specialist families, pharmacies and market stalls. Formulas were adjusted when ingredients were unavailable, prompting disputes over substitutions and the identity of a drug. A Chinese name could denote one species, a plant part, an unrelated substitute or a processed material. Early catalogues addressed such problems with provenance, harvesting dates, diagrams and preparation rules, showing that standardisation has long been a practical concern.

Ming dynasty synthesis and Li Shizhen

Ming printing, travel and domestic trade supported another leap in documentation. Li Shizhen spent decades compiling the Bencao Gangmu, published in 1578 after more than a quarter-century of revision. Its approximately 1,892 substances, thousands of formulas and extensive illustrations gathered earlier scholarship, field observation and reports from readers. Li corrected errors, questioned false stories and recorded substances once dismissed as minor or inanimate.

The work organised an inherited pharmacopoeia and became a reference for later physicians, naturalists and European readers. Its importance lies in scale and method: a critical compiler compared botanical description, preparation, experience and hearsay rather than repeating authority uncritically. Li did not separate what we now call chemistry, materia medica and medical history; that interdependence suited his period and still shapes how the text is read.

Ming formularies also record a culture in which medicine, cooking and long-term nourishment overlapped. Recipes for seasonal foods, women's health, ageing and convalescence circulated among households as well as clinics. Some knowledge stayed within families and passed orally, so the surviving canon represents only part of the tradition. By Li Shizhen's era, however, materia medica had become a major scholarly genre capable of preserving, disputing and reshaping knowledge.

Qing change and nineteenth-century encounters

The Qing court sponsored supplements to the Bencao Gangmu, while Jesuit and scientific contacts brought European botany and pharmacology into discussions of Chinese drugs. Officials compared foreign names, specimens and therapeutic claims with older entries. Yet Qing medicine remained shaped by local lineages, household remedies and the demands of epidemics and famine. The period shows that catalogues grew through both isolation and exchange.

During the nineteenth century, Western imperial medicine, missionary medicine and industrial pharmaceuticals transformed the marketplace and the status of Chinese practitioners. Opium became a notorious commodity, while new hospitals and drug firms created formidable competition. Chinese medical advocates defended classical theory, modernised it, or tested selected remedies through chemistry and experiment. Japan's institutional reforms also influenced how Chinese practitioners and policymakers imagined scientific legitimacy.

Republican China then built hospitals, medical schools, research institutes and national formularies, often treating Chinese medicine as a national resource as well as a clinical system. After 1949, campaigns promoted mass training, rural access and attempts to standardise or “modernise” the tradition. The Cultural Revolution disrupted teaching and research; its aftermath brought renewed debate over cultural identity, safety, professionalisation and integration with national healthcare.

Modern evidence, standardisation and safety

Contemporary Chinese herbal medicine spans specialist prescribing and industrialised products. Clinics often weigh herbs into individual formulas and prepare them as decoctions, with packets labelled for the patient. Retail products include fixed-formula granules, tablets and proprietary remedies requiring consistent botanical identity, dosage and manufacturing quality. Modern pharmacopoeias help, while testing for pesticides, heavy metals, adulterants and microbial contamination has become increasingly important.

Traditional use supplies historical evidence, but longevity is not proof of efficacy for every condition. Modern evaluation combines observation, randomised trials, systematic reviews, pharmacognosy and laboratory research. Some compounds have well-characterised biological actions, while the effects of a multi-herb formula cannot always be reduced to one isolated substance. Study design, suitable outcomes and variation among products remain central issues, and positive findings need replication.

Related forms of care often appear beside herbal prescribing. A discussion of sinusitis acupuncture techniques shows how diagnostic attention used in formula selection can shape point selection for nasal symptoms, although the modalities are distinct. Safety likewise requires attention to dose, preparation, pregnancy, liver and kidney function, allergies, and interactions with anticoagulants, antiplatelet drugs and other medicines. Clear records and informed referral are essential to responsible practice.

International policy has made the field more visible without making regulation uniform. The World Health Organization now includes traditional medicine patterns in its classification work and has adopted a global strategy for traditional medicine. Countries differ in definitions, practitioner licensing, product registration and research requirements. Chinese herbal medicine therefore reaches new societies through consultations, manufactured remedies, pharmacy trade and migration, each carrying different standards and assumptions.

Chinese herbal medicine in contemporary Australia

Australia illustrates adaptation. Chinese medicine practitioners are registered with the Chinese Medicine Division of the Australian Health Practitioner Regulation Agency, and many work in dedicated clinics around Melbourne's and Sydney's Chinatowns or through online consultations. In everyday speech, people may ask for a “TCM practitioner” or “Chinese herbalist”; the formal professional title is Chinese medicine practitioner, while qi is commonly pronounced “chee” in English.

The market combines professional dispensaries with retail channels. Supermarkets and Asian grocers in Melbourne, Sydney, Adelaide and Brisbane sell goji berries, ginger, licorice and dang gui, whereas clinics supply tailored prescriptions in measured packages. The Therapeutic Goods Administration maintains the Australian Register of Therapeutic Goods. Listed medicines are intended for lower-risk uses, while registered medicines face stricter evidence, quality and sponsor requirements; labels and advertising also fall under federal and state rules.

Many consultations are paid privately because Medicare generally does not rebate Chinese medicine, although some private health funds provide “extras” cover. Cost, duration and product quality therefore influence demand. Alongside herbal care, some clinics offer acupuncture for musculoskeletal problems; the sports injury case studies offer examples from a clinic setting and should be read as a separate modality, not evidence for herbal efficacy.

Safe use in Australia depends on communication across health systems. Practitioners should ask about prescriptions, supplements, allergies, pregnancy and organ disease, while patients can ask a pharmacist or general practitioner to check unfamiliar products. Raw botanical imports must meet border and biosecurity requirements, and internet sales do not remove the need for credible labelling. The tradition's future here will be shaped by historical knowledge, transparent standards and careful clinical reasoning rather than nostalgia alone.